Editorial & Opinion
[Pembrolizumab in adjuvant therapy in non-small cell lung cancers].
| العنوان: | [Pembrolizumab in adjuvant therapy in non-small cell lung cancers]. |
|---|---|
| عنوان ترانسليتريتد: | Pembrolizumab en adjuvant dans le cancer bronchique non à petites cellules. |
| المؤلفون: | Lefèvre A; Département d'oncologie médicale, Gustave-Roussy, université Paris-Saclay, 94805 Villejuif, France. Electronic address: antoinel97@hotmail.fr., Tissot C; Hôpital privé de la Loire, 42100 Saint-Étienne, France. |
| المصدر: | Bulletin du cancer [Bull Cancer] 2024 Apr; Vol. 111 (4), pp. 334-336. Date of Electronic Publication: 2024 Mar 11. |
| نوع المنشور: | Letter |
| اللغة: | French |
| بيانات الدورية: | Publisher: Elsevier Country of Publication: France NLM ID: 0072416 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1769-6917 (Electronic) Linking ISSN: 00074551 NLM ISO Abbreviation: Bull Cancer Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Jan. 2015- : Paris : Elsevier Original Publication: Paris : Masson |
| مواضيع طبية MeSH: | Carcinoma, Non-Small-Cell Lung*/drug therapy , Lung Neoplasms*/drug therapy, Humans ; Antibodies, Monoclonal, Humanized ; Nivolumab ; Immunotherapy |
| فهرسة مساهمة: | Keywords: Adjuvant therapy; Cancer bronchique non à petites cellules; Immunotherapy; Immunothérapie; Non-small cell lung cancer; Pembrolizumab; Traitement adjuvant |
| المشرفين على المادة: | DPT0O3T46P (pembrolizumab) 0 (Antibodies, Monoclonal, Humanized) 31YO63LBSN (Nivolumab) |
| تواريخ الأحداث: | Date Created: 20240312 Date Completed: 20240326 Latest Revision: 20240326 |
| رمز التحديث: | 20240326 |
| DOI: | 10.1016/j.bulcan.2023.12.012 |
| PMID: | 38471995 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1769-6917 |
|---|---|
| DOI: | 10.1016/j.bulcan.2023.12.012 |